SCIENCE: Clinical assessment of dysphagia in neurodegeneration (CADN): development, validity and reliability of a bedside tool for dysphagia assessment

The CADN is a reliable, valid, brief, quantifiable, and easily deployed assessment of swallowing in neurodegenerative disease. It is thus ideally suited for both clinical bedside assessment and future multicentre clinical trials in neurodegenerative disease.

 

Click here for more details.

Tags: , , ,

Related Post

Understanding speech and language in KIF1A-associated neurological disorder

  • Posted on 17 June, 2025
    A new study published in the European Journal of Human Genetics provides the first systematic analysis of speech and language...
    Read more

    Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration

    • Posted on 15 May, 2025
      MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the...
      Read more

      Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals

      • Posted on 31 March, 2024
        Speech and language impairments are core features of the neurodevelopmental genetic condition Kleefstra syndrome. The speech, language and cognitive profile...
        Read more